Overview

Study to Investigate the Mechanism of Action of an Oral Enzyme Treatment With Bromelain, Trypsin and Rutoside Versus Placebo in Subjects With OsTeoarthritis

Status:
Recruiting

Trial end date:
2022-07-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the pharmacodynamic profile of an oral enzyme treatment with Bromelain, Trypsin and Rutoside in subjects with osteoarthritis.

Phase:

N/A

Details

Lead Sponsor:

Mucos Pharma GmbH & Co. KG

Collaborators:

Artialis
Nestlé

Treatments:

Wobenzym